Dynamic MRI, dynamic multidetector-row computed tomography (MDCT), and coregistered 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)/CT: Comparative study of capability for management of pulmonary nodules

Journal of Magnetic Resonance Imaging

Volumn 27, Issue 6, 2008, Pages 1284-1295

  Ohno, Yoshiharu ^a   Koyama, Hisanobu ^a   Takenaka, Daisuke ^a   Nogami, Munenobu ^a,b   Maniwa, Yoshimasa ^a   Nishimura, Yoshihiro ^a   Ohbayashi, Chiho ^c   Sugimura, Kazuro ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b INSTITUTE OF BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^c KOBE UNIVERSITY HOSPITAL   (Japan)

Author keywords

CT; Lung; MR; Nodule; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ENHANCEMENT; LUNG NODULE; MAJOR CLINICAL STUDY; MALE; MCNEMAR TEST; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; TUMOR CLASSIFICATION;

ADULT; AGED; AGED, 80 AND OVER; BACTERIAL INFECTIONS; CARCINOMA; COIN LESION, PULMONARY; DIAGNOSIS, DIFFERENTIAL; FEASIBILITY STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; HAMARTOMA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OBSERVER VARIATION; PNEUMONIA; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 44449099695     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21348     Document Type: Article

References (39)

1. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early lung cancer action project: overall design and findings from baseline screening. Lancet 1999;35:99-105.
2. Garg K, Keith RL, Byers T, et al. Randomized controlled trial with low-dose spiral CT for lung cancer screening: feasibility study and preliminary results. Radiology 2002;225:506-510.
3. Swensen SJ, Jett JR, Hartman TE, et al. CT screening for lung cancer: five-year prospective experience. Radiology 2005;235:259-265.
4. Swensen SJ, Morin RL, Schueler BA, et al. Solitary pulmonary nodule: CT evaluation of enhancement with iodinated contrast material - a preliminary report. Radiology 1992;182:343-347.
5. Swensen SJ, Brown LR, Colby TV, Weaver AL, Midthun DE. Lung nodule enhancement at CT: prospective findings. Radiology 1996; 201:447-455.
6. Swensen SJ, Viggiano RW, Midthun DE, et al. Lung nodule enhancement at CT: multicenter study. Radiology 2000;214:73-80.
7. Tateishi U, Nishihara H, Tsukamoto E, Morikawa T, Tamaki N, Miyasaka K. Lung tumors evaluated with FDG-PET and dynamic CT: the relationship between vascular density and glucose metabolism. J Comput Assist Tomogr 2002;26:185-190.
8. Jeong YJ, Lee KS, Jeong SY, Solitary pulmonary nodule: characterization with combined wash-in and wash-out features at dynamic multi-detector row CT. Radiology 2005;237:675-683.
9. Yi CA, Lee KS, Kim BT, et al. Tissue characterization of solitary pulmonary nodule: comparative study between helical dynamic CT and integrated PET/CT. J Nucl Med 2006;47:443-450.
10. Patz EF, Jr, Lowe VJ, Hoffman JM, et al. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 1993;188:487-490.
11. Dewan NA, Gupta NC, Redepenning LS, Phalen JJ, Frick MP. Diagnostic efficiency of PET-FDG imaging in solitary pulmonary nodules. Chest 1993;104:997-1002.
12. Bury T, Dowlati A, Paulus P, et al. Evaluation of the solitary pulmonary nodule by positron emission tomography imaging. Eur Respir J 1996;9:410-414.
13. Dewan NA, Shehan CJ, Reeb SD, Gobar LS, Scott WJ, Ryschon K. Likelihood of malignancy in a solitary pulmonary nodule: comparison of Bayesian analysis and results of FDG-PET scan. Chest 1997;112:416-422.
14. Bryant AS, Cerfolio RJ. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules. Ann Thorac Surg 2006;82:1016-1020.
15. Webb WR. Radiologic evaluation of the solitary pulmonary nodule. AJR Am J Roentgenol 1990;154:701-708.
16. Gaeta M, Barone M, Russi EG, Carcinomatous solitary pulmonary nodules: evaluation of the tumor-bronchi relationship with thin-section CT. Radiology 1993;187:535-539.
17. Kusumoto M, Kono M, Adachi S, et al. Gadopentetate-dimeglumine-enhanced magnetic resonance imaging for lung nodules. Differentiation of lung cancer and tuberculoma. Invest Radiol 1994; 29:S255-S256.
18. Guckel C, Schnabel K, Deimling M, Steinbrich W. Solitary pulmonary nodules: MR evaluation of enhancement patterns with contrast-enhanced dynamic snapshot gradient-echo imaging. Radiology 1996;200:681-686.
19. Ohno Y, Hatabu H, Takenaka D, Adachi S, Kono M, Sugimura K. Solitary pulmonary nodules: potential role of dynamic MR imaging in management: initial experience. Radiology 2002;224:503-511.
20. Schaefer JF, Vollmar J, Schick F, et al. Solitary pulmonary nodules: dynamic contrast-enhanced MR imaging - perfusion differences in malignant and benign lesions. Radiology 2004;232:544-553.
21. Kim JH, Kim HJ, Lee KH, Kim KH, Lee HL. Solitary pulmonary nodules: a comparative study evaluated with contrast-enhanced dynamic MR imaging and CT. J Comput Assist Tomogr 2004;28: 766-775.
22. Ohno Y, Hatabu H, Takenaka D, et al. Dynamic MR imaging: value of differentiating subtypes of peripheral small adenocarcinoma of the lung. Eur J Radiol 2004;52:144-150.
23. Chiang S, Cardi C, Matej S, et al. Clinical validation of fully 3-D versus 2.5-D RAMLA reconstruction on the Philips-ADAC CPET PET scanner. Nucl Med Commun 2004;25:1103-1107.
24. Ohno Y, Koyama H, Takenaka D, et al. Coregistered ventilation and perfusion SPECT using krypton-81m and Tc-99m-labeled macroaggregated albumin with multislice CT utility for prediction of postoperative lung function in non-small cell lung cancer patients. Acad Radiol 2007;14:830-838.
25. Ohno Y, Koyama H, Nogami M, et al. STIR turbo SE MR imaging vs. coregistered FDG-PET/CT: quantitative and qualitative assessment of N-stage in non-small-cell lung cancer patients. J Magn Reson Imaging 2007;26:1071-1080.
26. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-310.
27. Littleton JT, Durizch ML, Moeller G, Herbert DE. Pulmonary masses: contrast enhancement. Radiology 1990;177:861-871.
28. Dean PB, Niemi P, Kivisaari L, Kormano M. Comparative pharmacokinetics of gadolinium DTPA and gadolinium chloride. Invest Radiol 1988;23:S258-S260.
29. Frouge C, Guinebretiere JM, Contesso G, et al. Correlation between contrast enhancement in dynamic magnetic resonance imaging of the breast and tumor angiogenesis. Invest Radiol 1994;29:1043-1049.
30. Sipkins DA, Cheresh DA, Kazemi MR, et al. Detection of tumor angiogenesis in vivo by alpha Vbeta 3-targeted magnetic resonance imaging. Nat Med 1998;4:623-626.
31. Knopp MV, Weiss E, Sinn HP, et al. Pathophysiologic basis of contrast enhancement in breast tumors. J Magn Reson Imaging 1999;10:260-266.
32. Wood DA, Miller M. The role of the dual pulmonary circulation in various pulmonary conditions of the lungs. J Thorac Surg 1938;7: 649-670.
33. Wright D. The blood supply of abnormal tissues in the lungs. J Pathol 1938;47:489-499.
34. Cudkowicz L. Some observations of the bronchial arteries in lobar pneumonia and pulmonary infection. Br J Dis Chest 1952;46:99-102.
35. Cudkowicz L. The bronchial circulation in pulmonary tuberculosis. In: The human bronchial circulation in health and disease. Baltimore: Williams & Wilkins, 1968. p 229-250.
36. Charan NB, Turk GM, Dhand R. The role of bronchial circulation in lung abscess. Am Rev Respir Dis 1985;131:121-124.
37. Robins. Acute and chronic inflammation. In: Cotran RS, Kumar V, Collins T, editors. Pathologic basis of disease, 6th edition. Philadelphia: W.B. Saunders, 1999. p 50-88.
38. Levitzky MG. Blood flow to the lung. In: Pulmonary physiology, 5th edition. New York: McGraw-Hill, 1999. p 85-111.
39. Milne EN. Circulation of primary and metastatic pulmonary neoplasms. A postmortem microarteriographic study. Am J Roentgenol Radium Ther Nucl Med 1967;100:603-619.